CRESCENT BIOPHARMA, INC. (CBIO) › Total AssetsCRESCENT BIOPHARMA, INC. (CBIO) — Total AssetsAnnual figures by fiscal year, from SEC filings.2013: $5.28M2014: $57.26M2015: $48.46M2016: $42.39M2017: $128.58M2018: $214.84M2019: $167.97M2020: $142.83M2021: $94.35M2022: $51.81M2023: $45.32M2024: $35.62M2025: $240.29M$240.29M2013Total Assets (USD)2025Fiscal YearTotal AssetsChange YoY2025$240.29M+574.7%2024$35.62M-21.4%2023$45.32M-12.5%2022$51.81M-45.1%2021$94.35M-33.9%2020$142.83M-15.0%2019$167.97M-21.8%2018$214.84M+67.1%2017$128.58M+203.3%2016$42.39M-12.5%2015$48.46M-15.4%2014$57.26M+983.8%2013$5.28M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share